Multiplikator Forward P/S: Beta Bionics (BBNX)
Beta Bionics Inc (BBNX) faces slow technology adoption and a dependence on insurance. However, robotic microelectronics assembly lines minimize defects. The forward P/S based on GURU.Markets forecasts utilizes data from the chart, where the latest parameter is 7.00, confirming the market valuation. Scaling sales of the iLet system creates operating leverage, significantly reducing per-unit production costs.
Ringkesan rincian data analitis iLet Bionic Pancreas (BBNX)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Beta Bionics Inc|BBNX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Beta Bionics Inc|BBNX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku iLet Bionic Pancreas|BBNX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Beta Bionics|Rasio cepet betabionics.com
- rincian asil keuangan lan kelipatan valuasi:
BBNX - Penghasilan resik perusahaan|Bathi sing dikarepake Beta Bionics Inc|BBNX - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Beta Bionics Corp|BBNX - Pangali PEG|Pangali EV/EBITDA iLet Bionic Pancreas|BBNX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Beta Bionics|BBNX - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan betabionics.com|BBNX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Beta Bionics Inc
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:BBNX (Beta Bionics)
The forward P/S reflects a scalability premium through the projected ratio of market capitalization to revenue. This metric measures market expectations for expansion, reacting to any changes in revenue generation rates. By analyzing the expected price-to-sales ratio, an investor determines the boundaries of the asset's fair value. For Beta Bionics Inc (BBNX), this indicator is critical, as pump distribution costs are temporarily outpacing operating cash flow.
Karo sapa Beta Bionics Inc saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|IRMD (Iradimed) - Multiplikator forward rega marang pendapatan|Embecta Health - Rega forward marang dodolan|TNDM (Tandem Diabetes Care) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep axogeninc.com AXGN|Rasio rega marang prakiraan pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Prakiraan rega marang pendapatan|Bioventus Corp - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake blade.com SRTA|Carlsmed (CARL) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RXST (RxSight Inc)|Rasio rega marang prakiraan pendapatan ClearPoint Neuro Inc.|Multiplikator forward rega marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator Forward P/S STIM|SGHT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|VANI: Multiplikator Forward P/S|XTNT (Xtant Medical) - Rasio rega marang prakiraan pendapatan|NMTC (NeuroOne Medical Technologies Corporation) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Modular Med MODD|Multiplikator forward rega marang pendapatan MYO (Myomo, Inc)|Rasio rega marang pendapatan sing dikarepake COCH|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|Multiplikator Forward P/S envveno.com NVNO|SINT: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan TNON (Tenon Medical Inc.)|LFWD: Multiplikator Forward P/S|AMIX (Autonomix Medical) - Rasio rega marang prakiraan pendapatan|IVF (INVO Fertility Inc) - Multiplikator Forward P/S|bonebiologics.com (BBLG) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Axonics (AXNX)|BIOL - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Dynatronics DYNT|FNA: Kapitalisasi marang prakiraan pendapatan|INVO Bio - Multiplikator Forward P/S
